Cancer patient-reported measures (PRMs)

Putting people with cancer at the centre of their care .

The cancer PRMs program helps people with cancer share how they are feeling and what matters most to them. This information helps healthcare teams better support patients and improve cancer care across NSW.

What are PRMs?

Gathering PRMs involves asking cancer patients about their experiences, symptoms and outcomes. There are two categories of PRMs, patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs).

Patient-reported measures (PRMs)

PROMs: Patient-reported outcome measures

A person with cancer’s perspective on their wellbeing (including how cancer treatment is impacting them) and how distressed they are feeling.

PREMs: Patient-reported experience measures

A person with cancer’s perception of their experiences within the healthcare system.

Listening to people with cancer, improving care:
The impact of PRMs at every level

Pictogram of a person with their arm wrapped around another

Person with cancer

When a person with cancer shares how they’re feeling in real time, care teams can respond faster to their needs, provide the right support and strengthen partnerships in care.

Pictogram of a battery where physicalconcerns and emotional concerns fill up most of the battery.

Clinicians

Through insights gathered from PRMs, clinicians are able to better understand the person behind the diagnosis, their overall wellbeing and provide holistic care.

Pictogram of hands surrounding a heart to represent care.

Cancer services

PRMs enables cancer services to identify people who need the most support. Aggregated data also inform clinical workflows, models of care, service reviews and quality improvement.

Broader NSW Health system

PRMs data provides a rich (and growing) evidence base to inform policies on best practice care, enable research partnerships and foster collaboration across disciplines and sectors.

The PROMising Impact series

The PROMising Impact series showcases local innovation and leadership in implementing the cancer PRMs system and scaling routine collection of PROMs in clinical care.